Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Bill Steinman
Contributing Editor

World Bank debars Merck business unit

The World Bank debarred a business unit of a Merck subsidiary Wednesday for 12 months for a “fraudulent practice” involving a health project in Bangladesh.

Institutional Family Planning Services Department (IFPSD), a business unit of Merck Sharp & Dohme B.V.Continue Reading

Job: Director, International Legal and Compliance Counsel

Job Title: Director, International Legal and Compliance Counsel

Employer: MERCK & Co., Inc.

Location: Kenilworth, New Jersey USA

Description: The position of Director, International Legal and Compliance is responsible for providing a broad range of support for marketing operations outside the United States, involving innovative pharmaceutical and vaccine products, as well as established brands. … Continue Reading

Job: Director, Anti-Bribery/Corruption Compliance Officer

Job Title: Director, Anti-Bribery/Corruption Compliance Officer

Employer: Merck & Co., Inc

Location: Gwynedd, Pennsylvania USA

Description: The Director, ABC Compliance Officer, will be responsible for supporting high priority activities of the Company’s compliance program as they relate to the Prevention of Bribery and Corruption outside of the United States (“ABC Program”).… Continue Reading

Job: Sr. Specialist, Ethics & Compliance

Job Title: Sr. Specialist, Ethics & Compliance

Employer: Merck & Co., Inc.

Location: Gwynedd, PA, United States

Description: The Senior Specialist, will support the strategic execution of compliance systems and processes designed to facilitate adherence to international and national laws relating to anti-bribery and anti-corruption, monitoring and reporting and third party compliance and ethics investigations tracking.… Continue Reading

DOJ declination for Merck

Big-pharma Merck said an SEC filing Thursday that the DOJ has closed its FCPA investigation of the company.

Merck first disclosed in 2010 that it received letters from the DOJ and SEC asking for FCPA-related information about its activities in a number of countries.… Continue Reading

Pharma’s China crack up

The headlines from Tuesday’s ethiXbase Monitor, a daily email of global corruption and compliance news, tell the story.

Here are the first four items:

China: Glaxo Executive Says Changes in China to Cut Drug Prices
Published on Jul 24, 2013 03:00 am
GlaxoSmithKline Plc (GSK)’s head of emerging markets said after meeting with government officials in Beijing some employees may have broken China’s laws and pledged corporate changes that will deliver cheaper medicines.

Continue Reading

Docs collect billions for drug promos

ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.

A Nashville psychiatrist led the pack, earning more than $1 million during the past four years for promotional talks and consulting for seven drug companies.… Continue Reading